Payments to Acquire Property, Plant, and Equipment in USD of Regulus Therapeutics Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Regulus Therapeutics Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and change rate from 2010 to Q1 2025.
  • Regulus Therapeutics Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0.000, a 100% decline year-over-year.
  • Regulus Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $340K, a 44.5% decline from 2023.
  • Regulus Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $613K, a 69.8% increase from 2022.
  • Regulus Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $361K, a 43.8% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Regulus Therapeutics Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 -$229K -100% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q1 2024 $229K +$228K +22800% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q1 2023 $1K -$101K -99% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q1 2022 $102K +$49K +92.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q1 2021 $53K +$53K 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q1 2020 $0 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q1 2018 $0 -$139K -100% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2018
Q1 2017 $139K -$256K -64.8% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q1 2016 $395K +$159K +67.4% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017
Q1 2015 $236K +$161K +215% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016
Q1 2014 $75K -$2K -2.6% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015
Q1 2013 $77K -$277K -78.2% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014
Q1 2012 $354K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013

Regulus Therapeutics Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $340K -$273K -44.5% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 $613K +$252K +69.8% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 $361K +$110K +43.8% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $251K +$251K 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 $0 -$221K -100% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 $221K +$199K +905% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021
2018 $22K -$281K -92.7% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 $303K -$610K -66.8% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019
2016 $913K -$450K -33% 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019
2015 $1.36M +$217K +18.9% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 $1.15M +$346K +43.3% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017
2013 $800K -$351K -30.5% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016
2012 $1.15M +$684K +146% 01 Jan 2012 31 Dec 2012 10-K 19 Feb 2015
2011 $467K -$1.42M -75.2% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014
2010 $1.88M 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.